FP

Feng Peng

Merck & Co., Inc., Rahway, NJ, USA (United States) US

ORCID iD 0000-0002-2382-2862
133
Publications
3,842
Citations
29
H-Index
56
i10-Index
3.21
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Lung Cancer Treatments and Mutations (23) Synthetic Organic Chemistry Methods (14) Asymmetric Synthesis and Catalysis (12) Lung Cancer Research Studies (11) Lung Cancer Diagnosis and Treatment (10)

Affiliations

Jiangnan University
CN 2021 - 2016
Merck & Co., Inc., Rahway, NJ, USA (United States)
US 2025 - 2015
Fujian Medical University
CN 2020 - 2019
Apple (Israel)
IL 2023 - 2023
Valve (United States)
US 2023 - 2023

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now